Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics

Authors: Home, Philip D., McCrimmon, Rory J., Rosenstock, Julio, Blüher, Matthias, Pegelow, Katrin, Melas‐Melt, Lydie, Djaballah, Khier, Giorgino, Francesco

Source: Diabetes, obesity & metabolism. 25(3):656-663

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172977185.0x000001&indx=1&recIds=ETOCvdc_100172977185.0x000001

Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial

Authors: McCrimmon, Rory J., Home, Philip, Cheng, Alice, Giorgino, Francesco, Fonseca, Vivian, Souhami, Elisabeth, Alvarez, Agustina, Picard, Pascaline, Rosenstock, Julio

Source: Diabetes, obesity & metabolism. 24(12):2391-2399

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100163348008.0x000001&indx=1&recIds=ETOCvdc_100163348008.0x000001

An overview of insulin therapy for the non‐specialist.

Authors: Home, Philip D.¹ (AUTHOR) philip.home@newcastle.ac.uk

Source: Diabetes, Obesity & Metabolism. Mar2025, p1. 13p. 4 Illustrations, 4 Charts.

Future directions in insulin therapy

Authors: Home, Philip

Source: In Metabolism November 2021 124

Insulin therapy development beyond 100 years

Authors: Home, Philip D ^*, Mehta, Roopa

Source: In The Lancet Diabetes & Endocrinology October 2021 9(10):695-707

Heart failure management; a perspective from diabetes care

Authors: Itzhak, Baruch, Home, Philip

Source: In Diabetes Research and Clinical Practice June 2021 176

The evolution of insulin therapy

Authors: Home, Philip

Source: In Diabetes Research and Clinical Practice May 2021 175

Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison

Authors: Home, Philip D., Mehta, Roopa, Hafidh, Khadija A. S., Gurova, Olesya Y., Alvarez, Agustina, Serafini, Paul, Pourrahmat, Mir‐Masoud

Source: Diabetes, obesity & metabolism. 23(12):2660-2669

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100133149238.0x000001&indx=1&recIds=ETOCvdc_100133149238.0x000001

Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon‐like peptide‐1 receptor agonists: a systematic literature review and indirect treatment comparison

Authors: Home, Philip D., Aroda, Vanita R., Blonde, Lawrence, Guyot, Patricia, Shaunik, Alka, Fazeli, Mir Sohail, Goswami, Hardik, Kalra, Sanjay, Pourrahmat, Mir‐Masoud

Source: Diabetes, obesity & metabolism. 22(11):2170-2178

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111609985.0x000001&indx=1&recIds=ETOCvdc_100111609985.0x000001

Insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis

Authors: Home, Philip, Blonde, Lawrence, Kalra, Sanjay, Ji, Linong, Guyot, Patricia, Brulle‐Wohlhueter, Claire, Murray, Erin, Shah, Roshan, Sayre, Toby, Shaunik, Alka

Source: Diabetes, obesity & metabolism. 22(11):2179-2188

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111610011.0x000001&indx=1&recIds=ETOCvdc_100111610011.0x000001

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial

Authors: Bolli, Geremia B., Landgraf, Wolfgang, Bosnyak, Zsolt, Melas‐Melt, Lydie, Home, Philip D.

Source: Diabetes, obesity & metabolism. 22(9):1664-1669

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100107989774.0x000001&indx=1&recIds=ETOCvdc_100107989774.0x000001

Is Insulin Therapy Safe?

Authors: Home, Philip, Itzhak, Baruch

Source: American journal of therapeutics. 27(1):e106-e114

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185888788.0x000001&indx=1&recIds=ETOCvdc_100185888788.0x000001

2020 vision – An overview of prospects for diabetes management and prevention in the next decade

Authors: Wang, Chih-Yuan, Neil, David L., Home, Philip

Source: In Diabetes Research and Clinical Practice September 2018 143:101-112

A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes

Authors: Home, Philip, Shankar, R. Ravi, Gantz, Ira, Iredale, Carol, O'Neill, Edward A., Jain, Lokesh, Pong, Annpey, Suryawanshi, Shailaja, Engel, Samuel S., Kaufman, Keith D., Lai, Eseng

Source: In Diabetes Research and Clinical Practice April 2018 138:253-261

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%

Authors: Owens, David R., Landgraf, Wolfgang, Frier, Brian M., Zhang, Mei, Home, Philip D., Meneghini, Luigi, Bolli, Geremia B.

Source: Diabetes, obesity & metabolism. 21(2):321-329

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100077033568.0x000001&indx=1&recIds=ETOCvdc_100077033568.0x000001

Cardiovascular outcome trials of glucose-lowering medications: an update

Authors: Home, Philip

Source: Diabetologia. 62(3):357-369

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125285358.0x000001&indx=1&recIds=ETOCvdc_100125285358.0x000001

Insulin regimens and glycemic control in different parts of Europe over 4 years after starting insulin in people with type 2 diabetes: Data from the CREDIT non-interventional study

Authors: Blonde, Lawrence, Marre, Michel, Vincent, Maya, Brette, Sandrine, Pilorget, Valerie, Danchin, Nicholas, Vespasiani, Giacomo, Home, Philip

Source: In Diabetes Research and Clinical Practice November 2017 133:150-158

Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy

Authors: Home, Philip D., Ahrén, Bo, Reusch, Jane E.B., Rendell, Marc, Weissman, Peter N., Cirkel, Deborah T., Miller, Diane, Ambery, Philip, Carr, Molly C., Nauck, Michael A.

Source: In Diabetes Research and Clinical Practice September 2017 131:49-60

Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open‐label clinical trial

Authors: Home, Philip D., Lam, Raymond L. H., Carofano, Wendy L., Golm, Gregory T., Eldor, Roy, Crutchlow, Michael F., Marcos, Michael C., Rosenstock, Julio, Hollander, Priscilla A., Gallwitz, Baptist

Source: Diabetes, obesity & metabolism. 20(9):2220-2228

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100096015192.0x000001&indx=1&recIds=ETOCvdc_100096015192.0x000001

Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open‐label clinical trial

Authors: Hollander, Priscilla A., Carofano, Wendy L., Lam, Raymond L.H., Golm, Gregory T., Eldor, Roy, Crutchlow, Michael F., Marcos, Michael C., Rendell, Marc S., Home, Philip D., Gallwitz, Baptist, Rosenstock, Julio

Source: Diabetes, obesity & metabolism. 20(9):2229-2237

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100096015128.0x000001&indx=1&recIds=ETOCvdc_100096015128.0x000001